| payload |
{"created_at":"2026-04-07T05:08:57.369 {"created_at":"2026-04-07T05:08:57.369197+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/telix-pharmaceuticals-q1-group-revenue-rises-stock","value":{"fp":"08fd469d7f4c0baa","kind":"unusual_volume","published_at":"2026-04-07T02:35:31+00:00","source":"Nasdaq Markets","summary":"(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) reported that its group revenue for the first quarter of fiscal year 2016 increased about 24% to US$230 million, from US$186 million last year.","tickers":[],"title":"Telix Pharmaceuticals Q1 Group Revenue Rises; Stock Up","url":"https://www.nasdaq.com/articles/telix-pharmaceuticals-q1-group-revenue-rises-stock"}}... |